Evoke Pharma, Inc.
EVOK
$5.49
$0.081.48%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -4.48% | -7.15% | 19.91% | 23.55% | -5.41% |
| Total Receivables | 15.68% | 3.76% | 19.67% | 0.97% | 37.96% |
| Inventory | 20.64% | 19.55% | -9.79% | -9.43% | -7.47% |
| Prepaid Expenses | -44.91% | -28.42% | 398.91% | -61.69% | -45.63% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -7.91% | -10.71% | 20.60% | 31.41% | 339.68% |
| Total Current Assets | -1.85% | -5.84% | 22.79% | 15.67% | -2.55% |
|
|
|||||
| Total Current Assets | -1.85% | -5.84% | 22.79% | 15.67% | -2.55% |
| Net Property, Plant & Equipment | -11.46% | -9.99% | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -95.04% | 9.87% | -- | -- |
| Total Assets | -1.93% | -6.52% | 23.78% | 16.62% | -2.55% |
|
|
|||||
| Total Accounts Payable | 39.76% | 11.76% | 7.53% | -0.09% | 15.85% |
| Total Accrued Expenses | 12.82% | -11.66% | 17.39% | 11.94% | 17.40% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.04% | 0.04% | 1.19% | 0.00% | 0.00% |
| Total Finance Division Other Current Liabilities | -33.33% | 200.00% | -37.50% | 5.26% | -40.63% |
| Total Other Current Liabilities | -33.33% | 200.00% | -37.50% | 5.26% | -40.63% |
| Total Current Liabilities | 11.19% | 0.69% | 6.28% | 3.12% | 5.74% |
|
|
|||||
| Total Current Liabilities | 11.19% | 0.69% | 6.28% | 3.12% | 5.74% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -21.88% | -17.62% | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 10.93% | 0.51% | 7.32% | 3.12% | 5.74% |
|
|
|||||
| Common Stock & APIC | 0.08% | 0.08% | 2.91% | 2.35% | 0.34% |
| Retained Earnings | -1.21% | -1.01% | -0.93% | -1.04% | -1.01% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -25.11% | -17.00% | 60.42% | 64.62% | -23.80% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -25.11% | -17.00% | 60.42% | 64.62% | -23.80% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -25.11% | -17.00% | 60.42% | 64.62% | -23.80% |
|
|
|||||